Interestingly, our study found that MYL9 in CAFs can not only promote the EMT process of CRC, but also regulate the secretion of CCL2 and TGF-β1 through the ERK 1/2 pathway by binding to IQGAP1. The gene discussed is MYL9; the disease is colorectal carcinoma.